Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength (Descending) SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
10135-0774-01 10135-0774 Prednisone Prednisone 1.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Feb. 1, 2023 In Use
51655-0229-26 51655-0229 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Feb. 15, 2023 In Use
51655-0229-52 51655-0229 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral March 17, 2023 In Use
70518-1167-00 70518-1167 Prednisone Prednisone 1.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral May 11, 2018 May 19, 2020 No Longer Used
70934-0645-30 70934-0645 Prednisone PREDNISONE 1.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral March 26, 2020 In Use
13668-0462-01 13668-0462 Anagrelide Anagrelide 1.0 mg/1, 1.0 mg/1 Ancillary Therapy Platelet-Reducing Agent PDE-3 Inhibitor Oral June 30, 2017 In Use
13668-0462-30 13668-0462 Anagrelide Anagrelide 1.0 mg/1, 1.0 mg/1 Ancillary Therapy Platelet-Reducing Agent PDE-3 Inhibitor Oral June 30, 2017 In Use
13668-0462-74 13668-0462 Anagrelide Anagrelide 1.0 mg/1, 1.0 mg/1 Ancillary Therapy Platelet-Reducing Agent PDE-3 Inhibitor Oral June 30, 2017 In Use
69452-0350-01 69452-0350 Granisetron Hydrochloride Granisetron Hydrochloride 1.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Feb. 28, 2022 In Use
69452-0350-11 69452-0350 Granisetron Hydrochloride Granisetron Hydrochloride 1.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Feb. 28, 2022 In Use

Found 10,000 results in 11 milliseconds — Export these results